Location History:
- Thurcaston, GB (2013 - 2020)
- Leicestershire, GB (2013 - 2023)
- Leicester, GB (2000 - 2024)
Company Filing History:
Years Active: 2000-2024
Title: The Innovative Mind of Stephen J. Howgill
Introduction: Stephen J. Howgill, an accomplished inventor based in Thurcaston, GB, boasts an impressive portfolio of 17 patents. His contributions to the field of inhaler technology highlight his forward-thinking approach and commitment to improving patient care through innovative designs.
Latest Patents: Among his latest patents, two remarkable inventions stand out. The first is an energy storage mechanism for an inhaler, which features a housing equipped with a patient port and a cover that rotates between closed and open positions. This design enables the cover to drive a resilient structure, storing energy as it moves, thus optimizing the inhaler’s functionality. The second patent details an inhaler flow control mechanism that utilizes a breath actuated trigger. This mechanism enhances the inhalation flow, ensuring a smooth release of medication and allowing for greater control over the flow rate during medication delivery.
Career Highlights: Throughout his career, Stephen has worked with prominent companies, including 3M Innovative Properties Company and Kindeva Drug Delivery, L.P. His tenure at these companies has significantly influenced the advancement of drug delivery systems, particularly in the realm of inhalation devices.
Collaborations: In his journey as an inventor, Stephen has had the opportunity to collaborate with talented individuals, including coworkers Peter D. Hodson and Adam J. Stuart. These collaborations have fostered a creative environment where innovative ideas flourish and lead to impactful inventions.
Conclusion: Stephen J. Howgill is a visionary inventor whose work continues to make a significant impact on respiratory health. With his impressive patent portfolio and collaborative spirit, he exemplifies the essence of innovation in the field of inhaler technology, paving the way for future advancements in patient care.